BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20408512)

  • 1. Scleromyxedema presenting with neurologic symptoms: a case report and review of the literature.
    Marshall K; Klepeiss SA; Ioffreda MD; Helm KF
    Cutis; 2010 Mar; 85(3):137-40. PubMed ID: 20408512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature.
    Fleming KE; Virmani D; Sutton E; Langley R; Corbin J; Pasternak S; Walsh NM
    J Cutan Pathol; 2012 May; 39(5):508-17. PubMed ID: 22515222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
    Rey JB; Luria RB
    J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
    Manousaridis I; Loeser C; Goerdt S; Hassel JC
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease.
    Rongioletti F
    Semin Cutan Med Surg; 2006 Jun; 25(2):100-4. PubMed ID: 16908401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleromyxedema with histology resembling granuloma annulare.
    Mullangi S; Granter SR; Laubach JP; Lipworth AD
    Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual granulomatous variant of scleromyxedema.
    Stetsenko GY; Vary JC; Olerud JE; Argenyi ZB
    J Am Acad Dermatol; 2008 Aug; 59(2):346-9. PubMed ID: 18485525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papular mucinosis (discrete papular lichen myxedematosus).
    Bragg J; Soldano AC; Latkowski JA
    Dermatol Online J; 2008 May; 14(5):14. PubMed ID: 18627750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.
    Nieves DS; Bondi EE; Wallmark J; Raps EC; Seykora JT
    Cutis; 2000 Feb; 65(2):89-92. PubMed ID: 10696560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema.
    Shayegi N; Alakel N; Middeke JM; Schetelig J; Mantovani-Löffler L; Bornhäuser M
    Transl Res; 2015 Feb; 165(2):321-4. PubMed ID: 24999269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichen myxedematosus: a rare group of cutaneous mucinosis.
    Cárdenas-Gonzalez RE; Ruelas MEH; Candiani JO
    An Bras Dermatol; 2019; 94(4):462-469. PubMed ID: 31644623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
    do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
    Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized papular and sclerodermoid eruption: scleromyxedema.
    Serdar ZA; Altunay IK; Yasar SP; Erfan GT; Gunes P
    Indian J Dermatol Venereol Leprol; 2010; 76(5):592. PubMed ID: 20827020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful intravenous immunoglobulin treatment of atypical lichen myxedematosus associated with hypothyroidism and central nervous system involvement: case report and discussion of the literature.
    Macnab M; Kenny P
    J Cutan Med Surg; 2013; 17(1):69-73. PubMed ID: 23364155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papular mucinosis, or localized lichen myxedematosis (LM) (discrete papular type).
    Christman MP; Sukhdeo K; Kim RH; Meehan S; Rieder E; Sicco KL; Franks A
    Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scleromyxedema without paraproteinemia.
    Abarzúa AA; Giesen LF; Sandoval MO; González SB
    Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
    Mahévas T; Arnulf B; Bouaziz JD; Livideanu CB; Osio A; Servy A; Cribier B; Sassolas B; Jachiet M; Michel L; Aucouturier P; Lipsker D; Frances C; Sbidian E; Rybojad M; Descamps V; D'Incan M; Humbert P; Beylot-Barry M; Passeron T; de Moreuil C; Taha RY; Hermine O; Dupuy A; Barbarot S; Debarbieux S; Carpentier O; Brault F; Schmutz JL; Thomas-Beaulieu D; Modiano P; Zarnitsky C; Lifermann F; Baubion E; Limal N; Le Bras F; Le Moigne M; Tauber M; Talbot A; Prud'homme R; Peltier S; De Masson A; Battistella M; Bagot M; Mékinian A; Fain O
    Blood; 2020 Apr; 135(14):1101-1110. PubMed ID: 32027747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Encephalitic Syndrome Induced by Scleromyxedema.
    Magira EE; Malouchou A; Karathanasi V; Mavropoulou N; Siempos II; Vourlakou C; Sykaras A; Anastasiadis G
    Am J Med Sci; 2020 Aug; 360(2):192-195. PubMed ID: 32540147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical discrete papular lichen myxedematosus associated with monoclonal gammopathy: report of four cases and review of the literature.
    Hermans C; Goldscheider I; Ruzicka T; Rongioletti F
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2048-2051. PubMed ID: 27422288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleromyxedema: a case report and review of the literature.
    Allam M; Ghozzi M
    Case Rep Dermatol; 2013 May; 5(2):168-75. PubMed ID: 23874293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.